Evidence map›Paper›PMID 26369343›Full record

ReviewJournal of the American Society of Nephrology : JASN2016

New Solutions to Reduce Discard of Kidneys Donated for Transplantation.

Peter P Reese, Meera N Harhay, Peter L Abt, Matthew H Levine, Scott D Halpern

Abstract readReview
In one paragraph

Review in Journal of the American Society of Nephrology : JASN, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed.

  1. Article
  2. Article
  3. Assessing Deceased-Donor Kidneys Through Posttransplant Survival Prediction Algorithms.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026
    Article
  4. Label-free viability assessment ofBiomedical optics express · 2026
    Article
  5. Article
  6. Article
  7. No Kidney Left Behind: Rescuing Unused Donor Kidneys for Transplant at the First Centralized Assessment and Repair Center.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Deceased Donor Kidney Transplantation for Older Transplant Candidates: A New Microsimulation Model for Determining Risks and Benefits.Medical decision making : an international journal of the Society for Medical Decision Making · 2023
    Article
  13. Review
  14. The Independent Effects of Kidney Length and Vascular Plaque on Ten-Year Outcomes of Extended Criteria Donor Kidney Transplants.Transplant international : official journal of the European Society for Organ Transplantation · 2023
    Article
  15. Article
  16. Review
  17. Article
  18. Pretransplant kidney transcriptome captures intrinsic donor organ quality and predicts 24-month outcomes.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  19. Article
  20. Impact of Extending Eligibility for Reinstatement of Waiting Time After Early Allograft Failure: A Decision Analysis.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Peter P ReeseRenal-Electrolyte and Hypertension Division, Department of Biostatistics and Epidemiology and Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania; and peter.reese@uphs.upenn.edu.
Meera N HarhayRenal Division, Department of Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania.
Peter L AbtDepartment of Surgery, and.
Matthew H LevineDepartment of Surgery, and.
Scott D HalpernDepartment of Biostatistics and Epidemiology and Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania; and Division of Pulmonary, Allergy and Critical Care, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania;

Funding

HDAC2 Inhibition Mitigates Renal Ischemia Reperfusion InjuryR01DK106243 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI LEVINE, MATTHEW HOWARD · 2016 to 2020
$1.8M
Patterns and Implications of Functional Decline Among Kidney Transplant CandidatesK23DK105207 · NIDDK · DREXEL UNIVERSITY · PI HARHAY, MEERA NAIR · 2015 to 2019
$861k
Histone/Protein Deacetylase Inhibitors Minimize Renal Ischemia-Reperfusion InjuryK08DK092282 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI LEVINE, MATTHEW HOWARD · 2011 to 2015
$768k
NIDDK NIH HHS DK105207-01NIDDK NIH HHS K08 DK092282NIDDK NIH HHS K23 DK105207NIDDK NIH HHS R01 DK106243
6 · The paper itself

Abstract

Kidney transplantation is a cost-saving treatment that extends the lives of patients with ESRD. Unfortunately, the kidney transplant waiting list has ballooned to over 100,000 Americans. Across large areas of the United States, many kidney transplant candidates spend over 5 years waiting and often die before undergoing transplantation. However, more than 2500 kidneys (>17% of the total recovered from deceased donors) were discarded in 2013, despite evidence that many of these kidneys would provide a survival benefit to wait-listed patients. Transplant leaders have focused attention on transplant center report cards as a likely cause for this discard problem, although that focus is too narrow. In this review, we examine the risks associated with accepting various categories of donated kidneys, including discarded kidneys, compared with the risk of remaining on dialysis. With the goal of improving access to kidney transplant, we describe feasible proposals to increase acceptance of currently discarded organs.

Indexed as

Kidney TransplantationHumansMedical Waste DisposalTissue and Organ ProcurementTissue DonorsMedical Waste Disposalepidemiology and outcomeskidney transplantationoutcomes

Identifiers

PMID26369343
PMCPMC4814180

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.